New trends in patient management: risk-based therapy for febrile patients with neutropenia
Rolston KV;;
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1999Vol. 29pp. -
333
kv1999clinicalnew
Abstract
Standard management of febrile neutropenia includes the prompt administration of empirical, broad-spectrum, parenteral antibiotic therapy. This is generally done in a hospital-based setting. Although effective (overall survival of >90%), such therapy leads to prolonged hospitalization, excessive …